ATE500226T1 - Aripiprazolhemifumarat und verfahren zu dessen herstellung - Google Patents
Aripiprazolhemifumarat und verfahren zu dessen herstellungInfo
- Publication number
- ATE500226T1 ATE500226T1 AT07818336T AT07818336T ATE500226T1 AT E500226 T1 ATE500226 T1 AT E500226T1 AT 07818336 T AT07818336 T AT 07818336T AT 07818336 T AT07818336 T AT 07818336T AT E500226 T1 ATE500226 T1 AT E500226T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- aripiprazole hemifumarate
- hemifumarate
- aripiprazole
- crystalline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200600219A SI22381A (sl) | 2006-09-22 | 2006-09-22 | Aripiprazol hemifumarat, njegova kristalna oblikain postopki za njegovo pripravo |
SI200700135A SI22544A (sl) | 2007-06-08 | 2007-06-08 | Aripiprazol hemifumarat, njegova kristalna oblikain postopki za njegovo pripravo |
PCT/EP2007/008247 WO2008034628A1 (en) | 2006-09-22 | 2007-09-21 | Aripiprazole hemifumarate and process for its preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE500226T1 true ATE500226T1 (de) | 2011-03-15 |
Family
ID=38962941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07818336T ATE500226T1 (de) | 2006-09-22 | 2007-09-21 | Aripiprazolhemifumarat und verfahren zu dessen herstellung |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP2081904B1 (de) |
AT (1) | ATE500226T1 (de) |
DE (1) | DE602007012924D1 (de) |
EA (1) | EA016840B1 (de) |
SI (1) | SI2081904T1 (de) |
UA (1) | UA94624C2 (de) |
WO (1) | WO2008034628A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2533050T6 (pl) | 2006-05-16 | 2016-05-31 | Amicus Therapeutics Inc | Możliwości leczenia choroby Fabry'ego |
EP2233471A1 (de) | 2009-02-06 | 2010-09-29 | Adamed Sp. z o.o. | Salz aus 7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4.dihydro-2(1h)-chinolinon mit 5-sulfosalizyklischer säure und herstellungsverfahren |
CA2773003A1 (en) * | 2009-09-15 | 2011-03-24 | Ratiopharm Gmbh | Orally disintegrating pharmaceutical dosage form containing aripiprazole |
WO2014104989A1 (en) * | 2011-12-27 | 2014-07-03 | Mahmut Bilgic | Pharmaceutical compositions comprising aripiprazole |
WO2013100878A1 (en) * | 2011-12-27 | 2013-07-04 | Mahmut Bilgic | Pharmaceutical formulations comprising aripiprazole |
EP3065700A1 (de) * | 2013-11-07 | 2016-09-14 | Synthon B.V. | Im mund zerfallende pharmazeutische zusammensetzungen mit aripiprazol |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5006528A (en) * | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
US20060223820A1 (en) * | 2006-03-21 | 2006-10-05 | Chemagis Ltd. | Crystalline aripiprazole salts and processes for preparation and purification thereof |
-
2007
- 2007-09-21 SI SI200730574T patent/SI2081904T1/sl unknown
- 2007-09-21 AT AT07818336T patent/ATE500226T1/de not_active IP Right Cessation
- 2007-09-21 EA EA200900463A patent/EA016840B1/ru not_active IP Right Cessation
- 2007-09-21 WO PCT/EP2007/008247 patent/WO2008034628A1/en active Application Filing
- 2007-09-21 UA UAA200903931A patent/UA94624C2/uk unknown
- 2007-09-21 EP EP07818336A patent/EP2081904B1/de active Active
- 2007-09-21 DE DE602007012924T patent/DE602007012924D1/de active Active
Also Published As
Publication number | Publication date |
---|---|
EA200900463A1 (ru) | 2009-06-30 |
SI2081904T1 (sl) | 2011-05-31 |
WO2008034628A1 (en) | 2008-03-27 |
DE602007012924D1 (de) | 2011-04-14 |
UA94624C2 (uk) | 2011-05-25 |
EP2081904A1 (de) | 2009-07-29 |
EA016840B1 (ru) | 2012-07-30 |
EP2081904B1 (de) | 2011-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL193340A0 (en) | Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
IL194871A (en) | Compound linking to bir iap site, intermediate compound, process for compound preparation, method for making acceptable pharmaceutical salt, pharmaceutical preparation and use of compound for drug production | |
ZA201001015B (en) | (Carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
MX343620B (es) | Forma polimorfica de clorhidrato de pridopidina. | |
SG138588A1 (en) | New naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them | |
IL204556A0 (en) | (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament | |
ATE536864T1 (de) | Metoprololsuccinat tabletten mit verlängerter freisetzung und verfahren für deren herstellung | |
IL193341A0 (en) | Novel azacyclyl-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments | |
IL193339A0 (en) | Novel aminoalcohol-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments | |
AP2384A (en) | 1,2,4,5-tetrahydro-3H-benzazepine compounds, a process for their preparation and pharmaceutical compositions containing them. | |
AP2011005935A0 (en) | New Benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions comprising them. | |
IL188069A0 (en) | Process for preparing new tiotropium salts, new tiotropium salts as such and pharmaceutical compositions thereof | |
EA201200616A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола | |
ATE500226T1 (de) | Aripiprazolhemifumarat und verfahren zu dessen herstellung | |
EP2666773A8 (de) | Organische aminsalze aus azilsartan, herstellungsverfahren dafür und ihre verwendung | |
WO2011009533A3 (de) | 17-hydroxy-17-pentafluorethyl-estra-4,9(10) -dien-11-ethinylphenyl-derivate, verfahren zu deren herstellung und deren verwendung zur behandlung von krankheiten | |
WO2010079045A3 (en) | Crystalline salt forms of flibanserine | |
WO2008034912A3 (en) | Process for the synthesis of clopidogrel and new forms of pharmaceutically acceptable salts thereof | |
MX2011006721A (es) | Formulacion farmaceutica de fenofibrato nanonizado. | |
HK1111403A1 (en) | New naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them | |
IL209944A (en) | Phenyl-Alkyl Paprazine Compounds, Process for Preparation, Pharmaceutical Composition and Drug Containing them | |
HK1128462A1 (en) | Novel method for preparation of ammonium salts of esomeprazole | |
MX2010006218A (es) | Compuestos organicos. | |
EP2222624A4 (de) | Derivate von 4-nerolidylcatechol, pharmazeutische zusammensetzungen, die diese enthalten, und verfahren zu deren herstellung | |
ATE466863T1 (de) | Neue aminopyrrolo-ä1,2-aü-indol- und aminopyridazino-ä1,6-aü-indol-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen damit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |